Manufacture of Basic Pharmaceutical Products and Preparations

Entry 21 covers establishments that produce basic pharmaceutical substances and preparations, such as active pharmaceutical ingredients, bulk drugs, and finished dosage forms like tablets and injectables, intended for medical use. It excludes the manufacturing of medical devices, cosmetics and nutraceuticals, focusing on products that require a pharmacopoeia-based production process.